Senseonics Holdings (SENS)

$0.44 +0.00 (0.68%)
Market Cap 342.17M
Revenue (ttm) 22.47M
Net Income (ttm) -78.62M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -349.89%
Debt to Equity Ratio 0.37
Volume 6,378,656
Avg Vol 7,343,204
Day's Range N/A - N/A
Shares Out 814.68M
Stochastic %K 20%
Beta 0.83
Analysts Sell
Price Target $1.43

Company Profile

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for r...

Industry: Medical Devices
Sector: Healthcare
Phone: 301 515 7260
Fax: 833 552 7007
Address:
20451 Seneca Meadows Parkway, Germantown, United States
Monticello4
Monticello4 Mar. 20 at 11:09 PM
$SENS .,.
0 · Reply
matmasr
matmasr Mar. 20 at 6:31 PM
$SENS I smell a trap
0 · Reply
Mobagri
Mobagri Mar. 20 at 4:43 PM
$DXCM $SENS when I thought you couldn’t be any more dumber, you proved me wrong. This is your analytical opinion about DXCM? It’s going private because institutions are buying. 😂😂😂😂😂. Are you looking for attention or are you the guy in sling blade?
0 · Reply
dlp02446
dlp02446 Mar. 20 at 4:35 PM
$SENS In case you're wondering what's going on with the market today, this is the largest witch we've had since 1996. Bloomberg Wall Street Faces a $5.7 Trillion Triple-Witching Jolt Today!
0 · Reply
dlp02446
dlp02446 Mar. 20 at 3:00 PM
$DXCM $SENS Hedge Funds Weigh In On DexCom Hedge funds and other institutional investors have recently modified their holdings of DXCM. Vanguard Group Inc. increased it's stake by 2.3%. Vanguard Group Inc. owns 49,456,043 shares worth $3,327,897,000 acquiring an additional 1,133,638. Geode Capital Management LLC boosted shares by 0.4% in the 4th quarter. Geode Capital Management LLC owns 11,006,183 shares valued at $727,842,000 after purchasing 42,411 shares last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted shares by 6.9%. UBS AM now owns 7,999,057 shares valued at $530,897,000 after buying 516,526 shares last quarter. Norges Bank bought DexCom in the 4th quarter worth about $483,356,000. Finally, Invesco Ltd. increased its position in shares of DexCom by 14.8%. Invesco Ltd. owns 5,315,367 sharesworth $352,781,000 after purchasing an additional 686,228 shares in the last quarter. Institutional investors own 97.75% of the company's stock.
0 · Reply
dlp02446
dlp02446 Mar. 20 at 2:36 PM
$DXCM $SENS I kind of understand what's going on with DXCM now. I was confused because the stock's not reacting to all the bad news in a normal fashion. Each time the stock drops, hedge funds are devouring the shares. With a 97% institutional ownership, this can mean one thing and one thing only...they are taking this sucker private. With a NEGATIVE 5 year return in one of the strongest markets ever in history, it will happen. When it does, I feel sorry for the retail investors. They will really get hit. If you've never been through that, I'm here as experience that you lose almost everything. Funds have come to the conclusion that the incompetent management are incapable of a turnaround. The incompetent management knows it's coming and they've been getting rid of shares. It may not be tomorrow, but it's coming!!!!!!!!!
0 · Reply
Punpire
Punpire Mar. 20 at 2:22 PM
$DXCM Dexcom used to be a solid stock and fairly reliable product. I'm not sure they will ever get back to $130 range, Congrats Dexcom, you've finally prevented users from resetting your CGM (G7) but at a terrible cost. Dexcom still gets most of the new diagnosed users but that will change in the coming years. $SENS has no marketing or sales force to speak of currently but hopefully that changes soon. Good luck $DXCM longs, you're going to need it. $SENS longs have very little hope right now but they at least have a reliable stress free product and when Gemini and Freedom hit it will start to take over.
0 · Reply
BMWLTWM3
BMWLTWM3 Mar. 19 at 7:59 PM
$SENS lmao...hits $6.67 and retreats, fun algo set by the craic comdians on the Trading desk
1 · Reply
Mobagri
Mobagri Mar. 19 at 6:11 PM
$SENS another pump and dump
2 · Reply
Mobagri
Mobagri Mar. 19 at 3:14 PM
$SENS devastating news coming out soon. Don’t be the last standing idiot.
3 · Reply
Latest News on SENS
First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

Mar 14, 2026, 10:15 AM EDT - 7 days ago

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript

Mar 2, 2026, 8:27 PM EST - 18 days ago

Senseonics Holdings, Inc. (SENS) Q4 2025 Earnings Call Transcript

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 2, 2026, 4:01 PM EST - 19 days ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

Feb 19, 2026, 8:00 AM EST - 4 weeks ago

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

Feb 19, 2026, 8:00 AM EST - 4 weeks ago

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Jan 29, 2026, 4:01 PM EST - 7 weeks ago

Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

Jan 8, 2026, 4:01 PM EST - 2 months ago

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

Senseonics: Eversense 365 Is A Game Changer For The CGM Industry

Dec 19, 2025, 10:18 AM EST - 3 months ago

Senseonics: Eversense 365 Is A Game Changer For The CGM Industry

Senseonics Holdings, Inc. (SENS) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 8:41 PM EST - 4 months ago

Senseonics Holdings, Inc. (SENS) Q3 2025 Earnings Call Transcript

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

Oct 22, 2025, 4:05 PM EDT - 5 months ago

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Oct 6, 2025, 4:05 PM EDT - 5 months ago

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript)

Sep 4, 2025, 11:23 AM EDT - 7 months ago

Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript)

Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics

Sep 3, 2025, 7:22 PM EDT - 7 months ago

Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

Sep 3, 2025, 5:17 PM EDT - 7 months ago

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 7:42 PM EDT - 8 months ago

Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript

Senseonics Holdings, Inc. Reports Second Quarter Financial Results

Aug 6, 2025, 4:05 PM EDT - 8 months ago

Senseonics Holdings, Inc. Reports Second Quarter Financial Results

Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

Jul 16, 2025, 4:05 PM EDT - 8 months ago

Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

Jun 4, 2025, 4:05 PM EDT - 10 months ago

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

May 21, 2025, 5:06 PM EDT - 10 months ago

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity

May 21, 2025, 3:35 AM EDT - 10 months ago

Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 15, 2025, 11:12 PM EDT - 11 months ago

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 15, 2025, 4:05 PM EDT - 11 months ago

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

Senseonics Holdings, Inc. (SENS) Q1 2025 Earnings Call Transcript

May 8, 2025, 7:55 PM EDT - 11 months ago

Senseonics Holdings, Inc. (SENS) Q1 2025 Earnings Call Transcript

Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

Apr 29, 2025, 4:05 PM EDT - 11 months ago

Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)

Apr 29, 2025, 7:30 AM EDT - 11 months ago

Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)

Senseonics Holdings, Inc. (SENS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 6:29 PM EST - 1 year ago

Senseonics Holdings, Inc. (SENS) Q4 2024 Earnings Call Transcript

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care

Feb 26, 2025, 7:30 AM EST - 1 year ago

Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 13, 2025, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Feb 6, 2025, 4:05 PM EST - 1 year ago

Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

Jan 8, 2025, 6:12 PM EST - 1 year ago

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

Senseonics Holdings, Inc. (SENS) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 6:33 PM EST - 1 year ago

Senseonics Holdings, Inc. (SENS) Q3 2024 Earnings Call Transcript

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

Oct 16, 2024, 4:30 PM EDT - 1 year ago

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor

Oct 10, 2024, 4:10 PM EDT - 1 year ago

Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor

Eversense 365 Launches in the US: One Year. One CGM.

Oct 1, 2024, 11:00 AM EDT - 1 year ago

Eversense 365 Launches in the US: One Year. One CGM.

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Sep 17, 2024, 7:00 AM EDT - 1 year ago

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference

Senseonics Holdings, Inc. (SENS) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 6:07 PM EDT - 1 year ago

Senseonics Holdings, Inc. (SENS) Q2 2024 Earnings Call Transcript

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time

Jul 25, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

Jun 21, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

Jun 13, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

May 29, 2024, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript

May 13, 2024, 7:52 PM EDT - 2 years ago

Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

May 13, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

May 13, 2024, 4:04 PM EDT - 2 years ago

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

May 9, 2024, 4:05 PM EDT - 2 years ago

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

May 2, 2024, 8:05 AM EDT - 2 years ago

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

Apr 30, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

Eversense® CGM System Receives iCGM Designation by the US FDA

Apr 30, 2024, 7:00 AM EDT - 2 years ago

Eversense® CGM System Receives iCGM Designation by the US FDA

Monticello4
Monticello4 Mar. 20 at 11:09 PM
$SENS .,.
0 · Reply
matmasr
matmasr Mar. 20 at 6:31 PM
$SENS I smell a trap
0 · Reply
Mobagri
Mobagri Mar. 20 at 4:43 PM
$DXCM $SENS when I thought you couldn’t be any more dumber, you proved me wrong. This is your analytical opinion about DXCM? It’s going private because institutions are buying. 😂😂😂😂😂. Are you looking for attention or are you the guy in sling blade?
0 · Reply
dlp02446
dlp02446 Mar. 20 at 4:35 PM
$SENS In case you're wondering what's going on with the market today, this is the largest witch we've had since 1996. Bloomberg Wall Street Faces a $5.7 Trillion Triple-Witching Jolt Today!
0 · Reply
dlp02446
dlp02446 Mar. 20 at 3:00 PM
$DXCM $SENS Hedge Funds Weigh In On DexCom Hedge funds and other institutional investors have recently modified their holdings of DXCM. Vanguard Group Inc. increased it's stake by 2.3%. Vanguard Group Inc. owns 49,456,043 shares worth $3,327,897,000 acquiring an additional 1,133,638. Geode Capital Management LLC boosted shares by 0.4% in the 4th quarter. Geode Capital Management LLC owns 11,006,183 shares valued at $727,842,000 after purchasing 42,411 shares last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted shares by 6.9%. UBS AM now owns 7,999,057 shares valued at $530,897,000 after buying 516,526 shares last quarter. Norges Bank bought DexCom in the 4th quarter worth about $483,356,000. Finally, Invesco Ltd. increased its position in shares of DexCom by 14.8%. Invesco Ltd. owns 5,315,367 sharesworth $352,781,000 after purchasing an additional 686,228 shares in the last quarter. Institutional investors own 97.75% of the company's stock.
0 · Reply
dlp02446
dlp02446 Mar. 20 at 2:36 PM
$DXCM $SENS I kind of understand what's going on with DXCM now. I was confused because the stock's not reacting to all the bad news in a normal fashion. Each time the stock drops, hedge funds are devouring the shares. With a 97% institutional ownership, this can mean one thing and one thing only...they are taking this sucker private. With a NEGATIVE 5 year return in one of the strongest markets ever in history, it will happen. When it does, I feel sorry for the retail investors. They will really get hit. If you've never been through that, I'm here as experience that you lose almost everything. Funds have come to the conclusion that the incompetent management are incapable of a turnaround. The incompetent management knows it's coming and they've been getting rid of shares. It may not be tomorrow, but it's coming!!!!!!!!!
0 · Reply
Punpire
Punpire Mar. 20 at 2:22 PM
$DXCM Dexcom used to be a solid stock and fairly reliable product. I'm not sure they will ever get back to $130 range, Congrats Dexcom, you've finally prevented users from resetting your CGM (G7) but at a terrible cost. Dexcom still gets most of the new diagnosed users but that will change in the coming years. $SENS has no marketing or sales force to speak of currently but hopefully that changes soon. Good luck $DXCM longs, you're going to need it. $SENS longs have very little hope right now but they at least have a reliable stress free product and when Gemini and Freedom hit it will start to take over.
0 · Reply
BMWLTWM3
BMWLTWM3 Mar. 19 at 7:59 PM
$SENS lmao...hits $6.67 and retreats, fun algo set by the craic comdians on the Trading desk
1 · Reply
Mobagri
Mobagri Mar. 19 at 6:11 PM
$SENS another pump and dump
2 · Reply
Mobagri
Mobagri Mar. 19 at 3:14 PM
$SENS devastating news coming out soon. Don’t be the last standing idiot.
3 · Reply
Waynoway
Waynoway Mar. 19 at 10:52 AM
$SENS So hand signals and rappers tell me something?? Lmaf
0 · Reply
Sammy4
Sammy4 Mar. 19 at 7:51 AM
$SENS
0 · Reply
InterStellarStacks
InterStellarStacks Mar. 19 at 7:17 AM
$SENS there’s clearly a huge amount of accumulation going on here
2 · Reply
BMWLTWM3
BMWLTWM3 Mar. 19 at 2:00 AM
$SENS sick fu*ks, even AH, has to be messaging somehow or Satin is working a trading desk. Senseonics Holdings, Inc. Common Stock (SENS) 6.34 -0.15 (-2.31%) At close: 4:00:01 PM EDT 6.66 +0.32 (+5.10%) After hours: 7:58:40 PM EDT
0 · Reply
SuperGreenToday
SuperGreenToday Mar. 18 at 11:27 PM
$SENS Share Price: $6.35 Contract Selected: Oct 16, 2026 $10 Calls Buy Zone: $1.15 – $1.42 Target Zone: $1.84 – $2.24 Potential Upside: 51% ROI Time to Expiration: 211 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
pathfinder63
pathfinder63 Mar. 18 at 2:17 PM
$SENS it seems this is what CCO doing on daily bases. He is enjoying his retirement in Bend Oregon and riding his bike 13 miles instead of doing an actual CCO work. A lot people including myself were happy when he joined the company but it turned out he is worst then Tim. Shame on them.
1 · Reply
stoley
stoley Mar. 18 at 8:27 AM
$SENS What am I asking for?? A few more days of green, and if possible in beautiful numbers?? That doesn't seem like an excessive request to me at all...😍😂
0 · Reply
Lupus_Leoque_Holdings
Lupus_Leoque_Holdings Mar. 17 at 11:33 PM
$SENS This ALONE is worth a follow... To the Feds: All content on this account is personal opinion only, based solely on publicly available information. Nothing here constitutes financial, investment, legal, or professional advice. We are not licensed, registered, or authorized by any regulatory or governmental body to provide investment services, recommendations, or solicitations, and no post may be interpreted as such. Any reference to securities or market activity is speculative commentary, and we may change or close positions at any time without notice. To the fullest extent permitted by law, we disclaim all liability for any loss, action, or decision arising from or related to this account. All content is provided for entertainment purposes only 🦁🐺
0 · Reply
pathfinder63
pathfinder63 Mar. 17 at 8:04 PM
$SENS I really dont agree with the way of their marketing effort but thought its worth it to share this. They need to do better than walking and counting miles. https://www.linkedin.com/posts/cheri-murray-b256a012a_teamwork-wellnessatwork-employeeengagement-share-7439429077913993216-6AZC?utm_source=share&utm_medium=member_android&rcm=ACoAABOViIYBbLqMyanSkeVzIDZayf61xJHbeZ4
0 · Reply
iSilenT
iSilenT Mar. 17 at 7:00 PM
$SENS Might regret this later, but borrowing fee and available shares at a new high. 1.8% borrowing fee with 10k shares available. Something is definitely brewing 🔥. MM is trying hard to suppress the stock. https://www.iborrowdesk.com/report/SENS
0 · Reply
Punpire
Punpire Mar. 17 at 6:59 PM
$SENS I'm hearing good things from ATTD 2026. Gemini and Freedom are getting close and the likes of Tandem and Omnipod will want to pair with it especially while Dexcom is losing long term customers since the G7 release.
1 · Reply
BMWLTWM3
BMWLTWM3 Mar. 17 at 6:00 PM
$SENS market makers playing games....cryptic msging.
0 · Reply